The rollout of updated Covid vaccines is marred by confusion, misinformation, and access barriers, especially for marginalized communities. Experts warn these issues could have dire public health consequences.
A new study suggests that a common allergy nasal spray may reduce COVID-19 infections by 67%. With limited vaccine access, could this over-the-counter solution be the future of viral protection?
